Yingying Hu

Cost-Effectiveness Analysis of Capecitabine Plus Oxaliplatin Versus Gemcitabine Plus Oxaliplatin as First-Line Therapy for Advanced Biliary Tract Cancers

Yalan Zhang, Ruijia Chen, Jinye Wang, 2022, Frontiers in Pharmacology.

The projections of global and regional rheumatic heart disease burden from 2020 to 2030

Zhi‐Gang She, Fang Lei, J. Qin, 2022, Frontiers in Cardiovascular Medicine.

The nonlinear relationship between thyroid function parameters and metabolic dysfunction-associated fatty liver disease

Zhi‐Gang She, Fang Lei, Xuewei Huang, 2023, Frontiers in Endocrinology.

Development and validation of a risk prediction nomogram for in-stent restenosis in patients undergoing percutaneous coronary intervention

Wenbo He, Changwu Xu, Da Luo, 2021, BMC Cardiovascular Disorders.

Lipoprotein(a) distribution and its association with carotid arteriopathy in the Chinese population.

P. Zhang, Zhibing Lu, Zhi‐Gang She, 2023, Atherosclerosis.

Long-Term Exposure to Fine Particulate Constituents and Vascular Damage in a Population with Metabolic Abnormality in China

Shujuan Yang, P. Zhang, Zhi‐Gang She, 2023, Journal of atherosclerosis and thrombosis.